What is the definition of critical illness myopathy in an intensive care unit patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Definition of Critical Illness Myopathy

Critical illness myopathy (CIM) is a specific neuromuscular disorder characterized by muscle fiber degeneration with loss of thick myosin filaments, presenting as profound muscle weakness in critically ill ICU patients, distinct from the broader umbrella term of ICU-acquired weakness (ICUAW). 1

Key Diagnostic Distinctions

CIM must be differentiated from the non-specific clinical diagnosis of ICUAW. While ICUAW is simply an umbrella term for any acquired weakness in ICU patients (including muscular inactivity and atrophy), CIM represents a specific pathophysiologic entity with distinct diagnostic criteria 2. The diagnosis of CIM requires electrophysiological confirmation and should not be conflated with the broader, less specific diagnosis of ICUAW 2.

Clinical Presentation

CIM typically manifests as:

  • Flaccid paralysis affecting limb and respiratory muscles
  • Difficulty weaning from mechanical ventilation due to respiratory muscle weakness
  • Onset after a brief ICU stay in patients with systemic inflammatory response syndrome 3
  • Muscle wasting that becomes apparent on examination 1

Pathophysiology

The defining pathologic feature is loss of thick myosin filaments in muscle tissue, distinguishing it from critical illness polyneuropathy (CIP), which involves axonal degeneration of peripheral nerves 1. These conditions may coexist as critical illness polyneuromyopathy (CIPNM) 4.

Diagnostic Approach

Electrophysiological studies are the most sensitive and specific examinations for diagnosing CIM, superior to both clinical assessment and muscle biopsy 2. The diagnostic workup includes:

  • Electromyography (EMG) - shows myopathic changes
  • Nerve conduction studies - helps differentiate from CIP
  • Muscle biopsy - may show myosin loss but has lower specificity 2
  • Clinical examination - Medical Research Council sum score, though this requires patient cooperation 5

Risk Factors

CIM develops in the context of:

  • Sepsis or systemic inflammatory response syndrome 6, 1
  • Prolonged mechanical ventilation
  • Multi-organ dysfunction 1
  • Hyperglycemia
  • Exposure to corticosteroids and neuromuscular blocking agents 1
  • ICU length of stay exceeding one week 7

Clinical Significance

CIM diagnosis carries stronger prognostic implications than the non-specific ICUAW diagnosis - patients with confirmed CIM have higher mortality during critical illness compared to those with ICUAW who don't meet CIM criteria 2. The condition is associated with:

  • Prolonged mechanical ventilation duration
  • Extended ICU and hospital stays 7
  • Persistent functional disabilities after discharge
  • Reduced quality of life in survivors 7

Important Caveats

The 2014 ATS guidelines use "ICUAW" as the overarching term 6, but more recent evidence suggests this non-specific diagnosis has limited clinical and research utility 2. For accurate prognosis, treatment planning, and research purposes, establishing the specific diagnosis of CIM through electrophysiological testing is superior to using the broad ICUAW label 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.